Alergias alimentarias en el niño evidencias y concenso

download Alergias alimentarias en el niño evidencias y concenso

of 6

Transcript of Alergias alimentarias en el niño evidencias y concenso

  • 8/12/2019 Alergias alimentarias en el nio evidencias y concenso

    1/6

    Original article

    Arch Dis Chi ld2011;96(Suppl 2):i25i29. doi:10.1136/adc.2011.214502 i25

    Accepted 4 May 2011

    ABSTRACTAims The Royal College of Paediatrics and ChildHealth (RCPCH) Science and Research Department wascommissioned by the Department of Health to developnational care pathways for children with allergies; foodallergy is the second pathway. The pathways focus ondefining the competences required to improve the equityof care received by children with allergic conditions.Method The food allergy pathway was developed bya multidisciplinary working group and was based on acomprehensive review of the evidence. The pathwaywas reviewed by a broad group of stakeholders includingthe public and approved by the Allergy Care PathwaysProject Board and the RCPCH Clinical StandardsCommittee. The National Institute of Health and ClinicalExcellence simultaneously established a short guidelinereview of community practice for children with foodallergy; close communication was established betweenthe two groups.Results The results are presented in two sections:

    a pathway algorithm and the competences. The entrypoints are defined and the ideal pathway of careis described from initial recognition and confirmeddiagnosis through to follow-up.Conclusions The range of manifestations of foodallergy/intolerance is much more diverse than hithertorecognised and diagnosis can be problematic as manypatients do not have classical IgE mediated disease. Thepathway provides a guide for training and developmentof services to facilitate improvements in delivery asclose to the patients home as possible. The authorsrecommend that this pathway is implemented locallyby a multidisciplinary team with a focus on creatingnetworks.

    INTRODUCTIONFood allergy is one of the earliest manifestationsof the allergic march.1Its presence is strongly cor-related with other atopic disorders.2It can be lifethreatening34and its presence erodes quality oflife.5For certain foods, allergy is likely to be longterm, if not life long.6Finally, the prevalence offood allergy appears to be increasing.7

    Quantifying the problem of food allergyDetermining the prevalence of food allergy using

    the World Allergy Organization (WAO)8 defini-tion is problematic as it requires demonstration

    of both sensitisation (in the case of IgE medi-ated reactions) as well as clinical reactivity, thelatter of which requires confirmation by a diffi-cult and labour intensive gold standard test thedouble blind placebo controlled food challenge(DBPCFC). Additional difficulties in determiningtrue prevalence stem from the natural history offood allergies. As the majority of children withcows milk and egg allergies outgrow these aller-gies during childhood,9a cross-sectional study ofchildren up to 18 years of age wil l not record foodallergy for those who have grown out of it.

    Questionnaire-based studies are very limited.It is well established that there is a significantdiscrepancy between self-reported food hyper-sensitivity (either allergy or intolerance) and thatwhich can be confirmed by objective tests.1013A number of studies have attempted to quantifythis discrepancy.101113Approximately 20% of atwo-stage UK community studied perceived that

    they had adverse food reactions. However, whenthese subjects underwent blinded food chal-lenges to eight common foods, only 1.41.8%were confirmed to have a true adverse food reac-tion.13More than 38% of children and adolescentsreported symptoms, but testing found only 4.2%were allergic.10Another study found that parentreported infant food allergy (33.7%) could only beconfirmed in 12.9% by testing and double blindplacebo controlled chal lenges.11

    Which foods?The WAO definition refers generically to food.The difficulty with establishing the true popula-tion prevalence is in determining to which foodschallenges should be undertaken. One solution isto focus on the most common allergenic foods.This varies between countries and between eth-nic and social groups within countries.14Two dif-ferent approaches are used. The first is to screenwith a broad panel of foods to identify whichmost frequently induce reactions. The alternat iveis to assess the frequency of reactions to specificfoods in the scientific literature.15

    Using the broad panel approach, it has beenfound that six foods (egg, peanut, milk, soy, wheatand fish) accounted for 86% of positive challenges,

    although tree nuts and sesame were not part ofthe panel.16New foods continue to be introduced,

    For numbered affiliations seeend of article

    Correspondence toAdam T Fox, Paediatric Allergy,St Thomas Hospital, LondonSE1 7EH, UK;[email protected]

    The RCPCH care pathway for food allergy inchildren: an evidence and consensus basednational approach

    Adam T Fox,1,2Kate Lloyd,3Peter D Arkwright,4Debi Bhattacharya,5Trevor Brown,6

    Philip Chetcuti,7Mandy East,8Jackie Gaventa,9Rosie King,10Ana Martinez,11Rosan Meyer,12Ami Parikh,13Michael Perkin,2Neil Shah,14David Tuthill,15Joanne Walsh,16Lisa Waddell,17John Warner18; on behalf of the Science andResearch Department, Royal College of Paediatrics and Child Health

    group.bmj.comon March 8, 2012 - Published byadc.bmj.comDownloaded from

    http://group.bmj.com/http://group.bmj.com/http://adc.bmj.com/http://group.bmj.com/http://adc.bmj.com/
  • 8/12/2019 Alergias alimentarias en el nio evidencias y concenso

    2/6

    Original article

    Arch Dis Chi ld2011;96(Suppl 2):i25i29. doi:10.1136/adc.2011.214502i26

    for example, kiwi17and lupin.18The common food allergensapproach found that food allergy to the eight most commonallergens (peanut, tree nuts, egg, milk, wheat, soybeans, fishand crustacean shellfish) was self-reported as 2.7%.

    Other reviews have found that food allergy affects morethan 12% but less than 10% of the population (table 1).19

    Risk factors

    Certain risk factors for food allergy have been identified. Moreboys than girls are reported to have had reactions, but morewomen reported reactions than men (p

  • 8/12/2019 Alergias alimentarias en el nio evidencias y concenso

    3/6

    Original article

    Arch Dis Chi ld2011;96(Suppl 2):i25i29. doi:10.1136/adc.2011.214502 i27

    not been assigned to specific health professionals or settingsin order to encourage flexibility in service delivery. However,it is envisaged that the provision of optimal care at all levels

    will require close liaison between different health professionalgroups including doctors, nurses and dieticians. All specialistsshould have paediatric training in line with the principles out-lined in the Childrens National Service Framework.60

    While the pathway is linear, it is important to recognise thatentry points can occur at any part of the pathway and that thepathway children follow may not be linear.

    External reviewThirteen of 53 (25%) invited organisations responded, provid-ing 119 comments. The comment period was over Decemberand this may have resulted in a lower than expected response.All comments were reviewed by the FAWG and the pathway

    was approved by the Allergy Care Pathways Project Board andthe RCPCH Clinical Standards Committee.

    Core knowledge documentsThe working group did not identify key guidelines (coreknowledge documents) supporting the skills required todeliver this pathway. However, the forthcoming publicationby the National Institute of Health and Clinical Excellence(NICE) is ant icipated to be a core knowledge document.

    DISCUSSIONThe aims and purpose of the RCPCH care pathway projectare described separately in this supplement.30 It remains a

    concern that the quality of care for children with suspectedfood allergy in the UK is currently variable, and often poor.

    A fundamental aim of the food allergy pathway is to improvethe path that children follow when food allergy is suspectedand to shorten the often long period before effective manage-

    ment is instituted. In infants food allergy and eczema oftenco-exist and this pathway seeks to reinforce the need forhealth professionals to consider allergic comorbidities. Foracute presentations into this pathway, the RCPCH anaphy-laxis care pathway should be consulted (http://www.rcpch.ac.uk/allergy/anaphylaxis).

    The entry points into the pathway are by acute anaphylacticpresentation, non-acute presentation and acute non-anaphylacticpresentation. Recognition of these symptoms will be required inmany community settings, particularly by health visitors and inprimary care, as well as in hospital emergency departments andin secondary care clinics. The challenge for this pathway willbe to determine a definitive diagnosis for food allergic childrenwith appropriate dietetic support. This pathway should aid the

    development of consistent management of children with foodallergy, avoiding unnecessary use of currently scarce tertiarycare resources. Setting the competence required to deliver carewill allow many children to be managed outside of the tertiarysetting without compromising the quality of care.

    Patienthealth professional partnershipThere is currently no cure for food allergy and it thereforelargely a chronic condition that requires ongoing manage-ment through avoidance strategies. The success of this workis dependent on the education of patients to appropriately self-care. In order to achieve this, healthcare professionals mustwork together with children, young people and their families.

    Schools, colleges and early years settings are also importantin supporting day-to-day adherence to the management plan,

    Figure 1 Food allergy pathway: methodology of evidence review.

    Literature Review and Expert Opinion

    Titles Screened [246]

    Stage 2: Titles and Abstracts screened

    [49]

    Stage 1:

    Reference Manager (de-duplication) [638]

    Stage 2: Systematic

    Review / PrimaryEvidence [36]

    Stage 3: CASP CriticalAppraisal / Data

    extraction

    Stage 3: AGREEAppraisal / Data

    extraction

    Stage 2: Guidelines[13]

    Handsearching referencelists of appraised papers [7]

    Include [23] Include [20] Include [6] Include [5]

    group.bmj.comon March 8, 2012 - Published byadc.bmj.comDownloaded from

    http://group.bmj.com/http://group.bmj.com/http://group.bmj.com/http://adc.bmj.com/http://group.bmj.com/http://adc.bmj.com/
  • 8/12/2019 Alergias alimentarias en el nio evidencias y concenso

    4/6

    Original article

    Arch Dis Chi ld2011;96(Suppl 2):i25i29. doi:10.1136/adc.2011.214502i28

    or indeed, providing information on events that might drivereview of the plan. Thus, liaison with educational facilitiesis a key item on the pathway for those with an acute foodallergy. Concordance, or the agreement between the patient/family and health professional to follow a particular strategy,should be clearly established at the outset and the health pro-fessional should continue to assess adherence to the jointlyagreed plan.

    Clinical implicationsNone of the RCPCH pathways define where (or by whom)care should be provided, but rather descr ibe the competencesrequired by the relevant health professional(s) to deliveroptimal care. To confirm a food allergy diagnosis, health-care professionals must be able to combine the findings ofan allergy focused clinical history with the results of scien-tifically validated allergy tests, in the case of IgE mediatedallergy, or the outcome of dietary exclusions and reintro-ductions, in the case of non-IgE mediated allergy. Much ofstandard management can occur close to the patients homewith onward referral on ly where the health professional no

    longer has the competence to deliver care. Complex manage-ment (eg, multiple food allergy or high risk of anaphylaxis)should only be delivered in a multi-disciplinary sett ing withaccess to a paediatric nurse with allergy training, a paediat-ric dietician and psychosocial support; within the currentprovision of allergy services this would most likely be a ter-tiary setting.

    This pathway has also been developed alongside the NICEguidance for diagnosis and assessment of food allergy in chil-dren and young people in primary care and community set-tings.61 These two documents complement each other andtogether offer clear guidance regarding initial assessment ofsuspected food allergy in primary care, the competencesneeded to safely deliver the care and appropriate referral.

    The rise in allergic disease over the past decades has beenthe subject of significant media attention and the possible roleof food as a cause of numerous childhood problems is reflectedin the findings of studies looking at the prevalence of foodallergies. Venter et al11found that over 33% of parents believedtheir child had reacted to a food by the age of 3. While thestudy was able to show that in most cases such reactions werenot reproducible, it does illustrate that there is a burden of anx-iety among parents whose children do not in fact have foodallergies. Their fears can only be allayed effectively in commu-nity based care if there are the competences to not only diag-nose food allergy effectively but also to use an allergy focusedclinical history and if necessary, diagnostic tests or exclusion

    diets, to rule it out.

    CONCLUSIONThe RCPCH food allergy care pathway describes the stepsin ideal care for children presenting with acute (anaphylaxisand non-anaphylaxis) and non-acute food allergic symptoms.Used in conjunction with the other papers within the RCPCHallergy care pathway portfolio (in press),305962 64it representsan opportunity to improve the lives of children with al lergiesin our community.

    Author Affiliations1Paediatric Allergy, St Thomas Hospital, London, UK2Division of Asthma, Allergy and Lung Biology, Guys and St Thomas NHSFoundation Trust, London, UK

    3Science and Research Department, Royal College of Paediatrics and Child Health,London, UK

    4Paediatric Allergy, University of Manchester, Royal Manchester ChildrensHospital, Manchester, UK5Pharmacy, NHS Norfolk, Norwich, UK6Paediatric Allergy, The Ulster Hospital, Dundonald, Belfast, UK7Paediatrics, Leeds Childrens Hospital, General Infirmary at Leeds, Leeds, UK8Anaphylaxis Campaign, Farnborough, UK9GOSH in Haringey, London, UK10Department of Allergy, Southampton University Hospital NHS Trust,Southampton, UK11Dermatology, Great Ormond Street Hospit al, London, UK12Dietetics, Imperial College NHS Healthcare Trust, London, UK13Paediatric A&E, Royal London Hospital, London, UK14Paediatric Gastroenterology, Great Ormond Street Hospital, London, UK15Department of Paediatrics, Childrens Hospital for Wales, University Hospital ofWales, Cardiff, UK16Primary Care, Roundwell Medical Centre, Norw ich, UK17Nottingham Community Nutrition and Dietetic Serv ice, CitiHealth, NHSNottingham City, Nottingham, UK18Department of Paediatrics, Imperial College, London, UK

    Acknowledgements We thank Ms Hilary Whitworth, a PhD Student at theUniversity of Southampton, who provided assistance for the evidence review,Dr Michael Perkin for contributing to the wr iting of the introduction of this paper,the RCPCH Allergy Care Pathways P roject Board who provided guidance andassistance and the RCPCH Clinical Standards team for their hard work on theapproval process, in particular Ms Katie Jones.

    Funding This project was funded by the Department of Health.

    Competing interests TB: MSD-UK, GSK, ALK-Abello, MEAD Johnson,Danone (Nutricia), Astra-Zeneca, Allergy NI, Schering P lough; ME: AnaphylaxisCampaign; AF: SHS International (from 2007), Danone, Mead Johnson, Lactofree,MSD, Schering-Plough, Meda, GSK, Phadia, Dorling Kindersley, ALK-Abello,Anaphylaxis Campaign, Allergy UK, Nestle, Allergy Therapeutics, Leaveitout.com,MyFoodFacts; JG: Allergy UK, Nestle Nutrition Institu te UK; NS: Nutricia; DT:Nutricia, SMA; JW: Novartis, Danone, Mead Johnson, Airsonette, Merck, AllergyTherapeutics, GSK, AstraZeneca.

    Provenance and peer review Not commissioned; not externally peer reviewed.

    REFERENCES1. WahnU.What drives the allergic mar ch?Allergy2000;55:5919.2. SchferT, Bhler E, Ruhdorfer S, et al.Epidemiology of food allergy/food

    intolerance in adults: associations with other manife stations of atopy.Allergy2001;56:11729.

    3. PumphreyRS.Fatal Anaphyla xis in the UK, 1992-2001. Novartis Found Symp2004;257:11628; discussion 2832, 5760, 27685.

    4. PumphreyRS, Gowland MH. Further fat al allergic reactions to food in the UnitedKingdom, 1999-2006.J Allergy Cl in Immunol2007;119:101819.

    5. Flokstra-de BlokBM, Dubois AE, Vlieg-Boerstra BJ, et al.Health-related qualityof life of food allergic patien ts: comparison with the general population and otherdiseases.Allergy2010;65:23844.

    6. FleischerDM.The natural histor y of peanut and tree nut allergy. Curr AllergyAsthma Rep2007;7:17581.

    7. GuptaR, Sheikh A, Str achan DP, et al.Time trends in allergic disorders in the UK.Thorax2007;62:916.

    8. JohanssonSG, Bieber T, Dahl R, et al.Revised nomenclature for allergy forglobal use: Report of the Nomenclature Review Committee of t he World AllergyOrganization, October 2003.J Allergy Cl in Immunol2004;113:8326.

    9. SampsonHA, Scanlon SM. Natural history of food hypersensitivity in childrenwith atopic dermatitis.J Pediatr1989;115:237.

    10. RoehrCC, Edenharter G, Reimann S, et al.Food allergy and non-allergic foo dhypersensitivity in children and adolescents. Clin Exp Allergy2004;34:153441.11. VenterC, Pereira B, Voigt K, et al.Prevalence and cumulative incidence of food

    hypersensitivity in the first 3 years of life.Allergy2008;63:3549.12. WoodsRK, Stoney RM, Raven J, et al.Reported adverse food reactions

    overestimate true food allergy in t he community.Eur J Clin Nutr2002;56:316.13. YoungE, Stoneham MD, Petruckevitch A, et al.A population study of food

    intolerance.Lancet1994;343:112730.14. KeilT, McBride D, Grimshaw K, et al.The multinational birth cohort of

    EuroPrevall: background, aims and methods.Allergy2010;65:48290.15. RonaRJ, Keil T, Summers C, et al.The prevalence of food allergy: a meta-

    analysis.J Allergy Cl in Immunol2007;120:63846.16. SampsonHA, McCaskill CC. Food hypersensitivity and atopic der matitis:

    evaluation of 113 patients.J Pediatr1985;107:66975.17. LucasJS, Grimshaw KE, Collins K, et al.Kiwi frui t is a significant allergen and is

    associated with differing patterns of reactivi ty in children and adults.Clin Exp Allergy2004;34:111521.

    18. ShawJ, Roberts G, Grimshaw K, et al.Lupin allergy in peanut-allergic childrenand teenagers.Allergy2008;63:3703.

    group.bmj.comon March 8, 2012 - Published byadc.bmj.comDownloaded from

    http://group.bmj.com/http://group.bmj.com/http://adc.bmj.com/http://group.bmj.com/http://adc.bmj.com/
  • 8/12/2019 Alergias alimentarias en el nio evidencias y concenso

    5/6

    Original article

    Arch Dis Chi ld2011;96(Suppl 2):i25i29. doi:10.1136/adc.2011.214502 i29

    19. ChafenJJ, Newberry SJ, Riedl MA, et al.Diagnosing and managing commonfood allergies: a systematic review.JAMA2010;303:184856.

    20. UguzA, Lack G, Pumphrey R, et al.Allergic reactions in the community: aquestionnaire survey of members of the anaphyl axis campaign. Clin Exp Allergy2005;35:74650.

    21. ChenW, Mempel M, Schober W, et al.Gender differe nce, sex hormones, andimmediate type hypersensitivity reactions.Allergy2008;63:141827.

    22. VassalloMF, Banerji A, Rudders SA, et al.Season of birth and food allergy inchildren.Ann Allergy Asthma Immunol2010;104:30713.

    23. BockSA.Prospective appraisal of complaints of adverse reactions to foods in

    children during the first 3 years of life. Pediatrics1987;79:6838.24. HourihaneJO, Dean TP, Warner JO. Peanut allergy in relat ion to heredity,

    maternal diet, and other atopic diseases: results of a questionnaire sur vey, skinprick testing, and food challenges.BMJ1996;313:51821.

    25. HillDJ, Heine RG, Hosking CS, et al.IgE food sensitization in infants with e czemaattending a dermatology department.J Pediatr2007;151:35963.

    26. HillDJ, Hosking CS. Food allergy and atopic dermatitis in infancy : anepidemiologic study.Pediatr Alle rgy Immunol2004;15:4217.

    27. HillDJ, Sporik R, Thorburn J, et al.The association of atopic dermatitis in infancywith immunoglobulin E food sensitization.J Pediatr2000;137:4759.

    28. HillDJ, Hosking CS, de Benedictis FM, et al.Confirmation of the associationbetween high levels of immunoglobulin E food sensitization and eczema ininfancy: an international study. Clin Exp Allergy2008;38:1618.

    29. SichererSH, Furlong TJ, Maes HH, et al.Genetics of peanut allergy: a twinstudy.J Allergy Cl in Immunol2000;106:536.

    30. WarnerJO, Lloyd K. Shared learning for chronic conditions: a methodology

    for developing the Royal College of Paediatrics and Child Health (RCPCH) carepathways for children with allergies.Arch Dis Chi ld2011;96(Suppl 2):i1i6.31. BernsteinIL, Li JT, Bernstein DI, et al.Allergy diagnostic testing: an updated

    practice parameter.Ann Allergy Asthma Immunol2008;100:S1148.32. SampsonHA, An JA. Summary and recommendations: Classification

    of gastrointestinal manifestations due to immunologic reactionsto foods in infants and young children.J Pediatr Gast roen tero l Nut r2000;30(Suppl):S8794.

    33. Du ToitG.Food-dependent exercise-induced anaphylaxis in childhood.PediatrAllergy Immunol2007;18:45563.

    34. Nowak-WegrzynA, Assaad AH, Bahna SL, et al.Work Group report: oral fo odchallenge testing.J Allergy Cli n Immunol2009;123:S36583.

    35. FiocchiA, Bouygue GR, Restani P,et al.Accuracy of skin prick tests in IgE-mediatedadverse reactions to bovine proteins.Ann Allergy Asthma Immunol2002;89:2632.

    36. LiccardiG, DAmato G, Canonica GW, et al.Systemic reactions from skin testing:literature review.J Investig A llergol Cli n Immunol2006;16:758.

    37. RancF, Deschildre A, Villard-Truc F, et al.Oral food challenge in children: an

    expert review.Eur Ann Alle rgy Clin Immunol2009;41:3549.38. SporikR, Hill DJ, Hosking CS. Specificity of allergen skin testing in predicting

    positive open food challenges to milk, egg and peanut in children. Clin Exp Allergy2000;30:15406.

    39. FurutaGT, Liacouras CA, Collins MH, et al.Eosinophilic esophagitis in childrenand adults: a systematic re view and consensus recommendations for diagnosisand treatment. Gastroenterology2007;133:134263.

    40. Miceli SopoS, Radzik D, Calvani M. The predictive value of specificimmunoglobulin E levels for the first diagnosis of cows milk allergy. A criticalanalysis of pediatric literature.Pediatr Allergy Immuno l2007;18:57582.

    41. American College of Allergy, Asthma, & Immunology. Food allergy: a practiceparameter.Ann Allergy Asthma Immunol2006;96:S168.

    42. KapoorS, Roberts G, By noe Y, et al.Influence of a multidisciplinary paediatricallergy clinic on parental knowl edge and rate of subsequent allergic reactions.Allergy2004;59:18591.

    43. PumphreyRS.Lessons for management of anaphylaxis f rom a study of fatalreactions. Clin Exp Allergy2000;30:114450.

    44. HuW, Grbich C, Kemp A. Parental food allergy infor mation needs: a qualitativestudy.Arch Dis Chi ld2007;92:7715.

    45. KlinnertMD, Robinson JL. Addressing the psychological needs of f amilies offood-allergic children. Curr Allergy Asthma Rep2008;8:195200.

    46. NICE. Atopic Eczema in Children. National Institute for Health and ClinicalExcellence, 2007.

    47. ClarkAT, Ewan PW. Good prognosis, clinical feature s, and circumstances ofpeanut and tree nut reactions in children tre ated by a specialist allergy center.

    J Allergy Cl in Immunol2008;122:2869.48. SinghJ, Aszkenasy OM. Prescription of adrenaline auto-injectors for potenti al

    anaphylaxisa population survey.Public Health 2003;117:2569.49. MuraroA, Roberts G, Clark A, et al.The management of anaphylaxis in

    childhood: position paper of the European academy of allergology and clinicalimmunology.Allergy2007;62:85771.

    50. Resuscitat ion Council UK. The Emergency Treatment of Anaphyl actic Reaction s Guidelines for Healthcare Providers. London: Resuscitation Council UK, 2008.

    51. EwanPW, Clark AT. Efficacy of a management plan based on severityassessment in longitudinal and case-controlled studies of 747 children with nutallergy: proposal for good practice. Clin Exp Allergy2005;35:7516.

    52. SheikhA, Shehata YA, Brown SG, et al.Adrenaline (epinephrine) for thetreatment of anaphylaxis with and without shock. Cochrane Database Syst Rev2008;4:CD006312.

    53. KempAS, Hill DJ, Allen KJ, et al.Guidelines for the use of infant for mulas to treatcows milk protein allergy: an Australian consensus panel opinion.Med J Aust

    2008;188:10912.54. NurmatovU, Worth A, Sheikh A. Anaphylaxis management plans for the acuteand long-term management of anaphylaxis: a systematic review.J Allergy Cl inImmunol2008;122:35361, 361.e13.

    55. AveryNJ, King RM, Knight S, et al.Assessment of quality of lif e in children withpeanut allergy.Pediatr Allergy Immunol2003;14:37882.

    56. KingRM, Knibb RC, Hourihane JO. Impact of peanut allergy on quality of life,stress and anxiety in the famil y.Allergy2009;64:4618.

    57. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for establishedatopic eczema. Cochrane Database Syst Rev2008;1:CD005203.

    58. YanBM, Shaffer EA. Primar y eosinophilic disorders of the gastrointestinal tract.Gut2009;58:72132.

    59. ClarkAT, Lloyd K, Sheikh A, et al.The Royal College of Paediat rics and ChildHealth (RCPCH) care pathway for children at risk of anaphylaxis: an evidence andconsensus based national approach to caring for children with life-threate ningallergies.Arch Dis Chi ld2011;96(Suppl 2):i6i9.

    60. Department of Health. National Service Framewor k for Children, Young People and

    Maternity Services, 2004. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4089100.

    61. National Institute for Health and Clinical Excellence (2011). Diagnosis andassessment of food allergy in children and young people in primary care andcommunity settings. London: National Institute f or Health and Clinical Excellence.Available from: www.nice.org.uk/guidance/CG116.

    62. VanceG, Lloyd K, Scadding G, et al.The unified airway : the Royal Collegeof Paediatrics and Child Health care pa thway for children with asthma and/orrhinitis.Arch Dis Chi ld2011;96(Suppl 2):i10i14.

    63. LeechSC, Lloyd K, Grattan C, et al.The RCPCH care pathway for children wi thUrticaria, Angio- oedema or Mastocytosis: an evidence and consensus basednational approach.Arch Dis Chi ld2011;96(Suppl 2):i34i 37.

    64. CoxHE, Williams HC, Lloyd K, et al.Emollients, education and qualityof life: the RCPCH care pathway for children wi th eczema.Arch Dis Chi ld2011;96(Suppl 2):i19i24.

    group.bmj.comon March 8, 2012 - Published byadc.bmj.comDownloaded from

    http://group.bmj.com/http://group.bmj.com/http://adc.bmj.com/http://group.bmj.com/http://adc.bmj.com/
  • 8/12/2019 Alergias alimentarias en el nio evidencias y concenso

    6/6

    doi: 10.1136/adc.2011.2145022011 96: i25-i29Arch Dis Child

    Adam T Fox, Kate Lloyd, Peter D Arkwright, et al.national approachchildren: an evidence and consensus basedThe RCPCH care pathway for food allergy in

    http://adc.bmj.com/content/96/Suppl_2/i25.full.htmlUpdated information and services can be found at:

    These include:

    References

    http://adc.bmj.com/content/96/Suppl_2/i25.full.html#related-urlsArticle cited in:

    http://adc.bmj.com/content/96/Suppl_2/i25.full.html#ref-list-1

    This article cites 58 articles, 10 of which can be accessed free at:

    serviceEmail alerting

    the box at the top right corner of the online article.Receive free email alerts when new articles cite this article. Sign up in

    CollectionsTopic

    (1005 articles)Immunology (including allergy)(16 articles)Press releases

    Articles on similar topics can be found in the following collections

    Notes

    http://group.bmj.com/group/rights-licensing/permissionsTo request permissions go to:

    http://journals.bmj.com/cgi/reprintformTo order reprints go to:

    http://group.bmj.com/subscribe/To subscribe to BMJ go to:

    group.bmj.comon March 8, 2012 - Published byadc.bmj.comDownloaded from

    http://adc.bmj.com/content/96/Suppl_2/i25.full.htmlhttp://adc.bmj.com/content/96/Suppl_2/i25.full.htmlhttp://adc.bmj.com/content/96/Suppl_2/i25.full.html#related-urlshttp://adc.bmj.com/content/96/Suppl_2/i25.full.html#related-urlshttp://adc.bmj.com/content/96/Suppl_2/i25.full.html#ref-list-1http://adc.bmj.com/cgi/collection/immunology_including_allergyhttp://adc.bmj.com/cgi/collection/immunology_including_allergyhttp://adc.bmj.com/cgi/collection/immunology_including_allergyhttp://adc.bmj.com/cgi/collection/immunology_including_allergyhttp://group.bmj.com/group/rights-licensing/permissionshttp://group.bmj.com/group/rights-licensing/permissionshttp://journals.bmj.com/cgi/reprintformhttp://journals.bmj.com/cgi/reprintformhttp://group.bmj.com/subscribe/http://group.bmj.com/http://group.bmj.com/http://group.bmj.com/http://adc.bmj.com/http://group.bmj.com/http://adc.bmj.com/http://group.bmj.com/subscribe/http://journals.bmj.com/cgi/reprintformhttp://group.bmj.com/group/rights-licensing/permissionshttp://adc.bmj.com/cgi/collection/immunology_including_allergyhttp://adc.bmj.com/cgi/collection/press_releaseshttp://adc.bmj.com/content/96/Suppl_2/i25.full.html#related-urlshttp://adc.bmj.com/content/96/Suppl_2/i25.full.html#ref-list-1http://adc.bmj.com/content/96/Suppl_2/i25.full.html